Since many BC cells and BCSCs are characterized by high expression of CD44 while others show low expression, we decided to select MDA-MB-231 as CD44+ and adenocarcinoma MCF-7 as CD44− cells, respectively (Figure S4), to study receptor-mediated endocytosis of NPs. Here, CD44 is linked to breast cancer.